Northern Trust’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Buy |
|
|||||
|
2025
Q1 | $348K | Buy |
|
|||||
|
2024
Q4 | $567K | Buy |
|
|||||
|
2024
Q3 | $557K | Buy |
|
|||||
|
2024
Q2 | $151K | Buy |
|
|||||
|
2024
Q1 | $116K | Sell |
|
|||||
|
2023
Q4 | $114K | Hold |
|
|||||
|
2023
Q3 | $94.9K | Hold |
|
|||||
|
2023
Q2 | $149K | Buy |
|
|||||
|
2023
Q1 | $56.1K | Hold |
|
|||||
|
2022
Q4 | $52.4K | Buy |
|
|||||
|
2022
Q3 | $43K | Hold |
|
|||||
|
2022
Q2 | $52K | Hold |
|
|||||
|
2022
Q1 | $86K | Hold |
|
|||||
|
2021
Q4 | $126K | Sell |
|
|||||
|
2021
Q3 | $287K | Hold |
|
|||||
|
2021
Q2 | $158K | Buy |
|
|||||
|
2021
Q1 | $116K | Buy |
|
|||||
|
2020
Q4 | $105K | Hold |
|
|||||
|
2020
Q3 | $118K | Buy |
|
|||||
|
2020
Q2 | $73K | Hold |
|
|||||
|
2020
Q1 | $57K | Hold |
|
|||||
|
2019
Q4 | $146K | Sell |
|
|||||
|
2019
Q3 | $82K | Sell |
|
|||||
|
2019
Q2 | $530K | Sell |
|
|||||
|
2019
Q1 | $606K | Sell |
|
|||||
|
2018
Q4 | $555K | Sell |
|
|||||
|
2018
Q3 | $1.3M | Buy |
|
|||||
|
2018
Q2 | $1.65M | Buy |
|
|||||
|
2018
Q1 | $1.02M | Buy |
|
|||||
|
2017
Q4 | $908K | Sell |
|
|||||
|
2017
Q3 | $1.43M | Buy |
|
|||||
|
2017
Q2 | $1.05M | Buy |
|
|||||
|
2017
Q1 | $910K | Buy |
|
|||||
|
2016
Q4 | $543K | Buy |
|
|||||
|
2016
Q3 | $575K | Buy |
|
|||||
|
2016
Q2 | $450K | Buy |
|